Qatar Genome and Qatar Biobank partnered with the Department of Genetic Medicine at Weill Cornell Medicine-Qatar, the Diagnostic Genomic Division at Hamad Medical Corporation as well as the Sidra research team at Sidra Medicine to facilitate the development of the first Qatari gene chip, known as the 'Q-Chip'. These collective national efforts aim to translate the outcomes of basic genomic research into high impact deliverables at the clinical care end specific to the Qatari population and the Arab Region.